Skip to main content

Table 2 Relationship between clinicopathological data and PGP 9.5 expression in invasive ductal carcinoma of the breast

From: The clinicopathological significance of neurogenesis in breast cancer

   PGP 9.5 expression  
  No. case Negative Positive P-value
Tumor size     P = 0.319
≤ 2 cm 86 30 (34.9%) 56 (65.1%)  
> 2 cm 58 25 (43.1%) 33 (56.9%)  
Tumor grade     P < 0.0001
I 34 24 (70.6%) 10 (29.4%)  
II - III 110 31 (28.2%) 79 (71.8%)  
Tumor stage     P = 0.834
I 23 10 (43.5%) 13 (56.5%)  
II 74 27 (36.5%) 47 (63.5%)  
III 47 18 (38.2%) 29 (61.8%)  
LN metastasis     P = 0.825
Negative 75 28 (37.3%) 47 (62.7%)  
Positive 69 27 (39.1%) 42 (60.9%)  
ER     P = 0.399
Negative 80 33 (41.3%) 47 (58.8%)  
Positive 64 22 (34.4%) 42 (65.6%)  
PR     P = 0.801
Negative 70 26 (37.1%) 44 (62.9%)  
Positive 74 29 (39.2%) 45 (60.8%)  
Disease free survival     P = 0.035
< 3 years 54 19 (22.2%) 35 (64.8%)  
≥ 3 years 90 48 (53.3%) 42 (46.7%)  
  1. LN Lymph node, ER Estrogen receptor, PR Progesterone receptor.